Quantification of poly(I:C)-mediated protection against genital herpes simplex virus type 2 infection

Pharmacology, Toxicology and Pharmaceutical Science

• Infection 100%
• Herpes Simplex Virus 2 100%
• Genital Herpes 100%
• Polyinosinic Polycytidylic Acid 100%
• Polyinosinic Acid 100%
• Polycytidylic Acid 100%
• Cytokine 20%
• Immunotoxicity 20%
• Antimicrobial Agent 20%
• Diseases 20%
• Nucleic Acid 10%
• Toll Like Receptor 3 10%
• Oligodeoxynucleotide 10%
• Toll Like Receptor 9 10%
• Vagina Discharge 10%

Keyphrases

• Herpes Simplex Virus Type 2 Infection 100%
• Genital Herpes Simplex Virus 100%
• Poly IC 100%
• Poly(C) 100%
• Herpes Simplex Virus 2 (HSV-2) 40%
• Microbicides 20%
• Immunotoxicity 20%
• Disease Resolution 20%
• Nucleic Acids 10%
• Toll-like 10%
• Genital Herpes 10%
• Therapeutic Agents 10%
• Cytokine Induction 10%
• Viral Challenge 10%
• In Vitro Data 10%
• TLR Agonists 10%
• Oligodeoxynucleotide 10%
• Novel Class 10%
• Cytokine Levels 10%
• Immunomodulatory 10%
• Disease Survival 10%
• Escalating Dose 10%
• Infectious Dose 10%
• Antiherpetic 10%
• Vaginal Lavage 10%
• TLR3 Agonist 10%
• Temporal Window 10%
• Human Vaginal Epithelial Cells 10%
• Vaginal Fluid 10%